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Intracellular trafficking is a determining factor in the transgene expression efficiency of gene vectors. In the present study, the mechanism of
the cellular uptake of octaarginine (R8)-modified liposomes, when introduced at 37 °C and 4 °C, was investigated in living cells. Compared with
37 °C, the uptake of R8-liposomes was only slightly reduced at 4 °C. Dual imaging of liposomes and plasma membranes revealed that R8-
liposomes were internalized by vesicular transport, and partially escaped to the cytosol at the perinuclear region at 37 °C. When introduced at
4 °C, intracellular liposomes were observed within a specific region close to the plasma membrane, and internalization of the plasma membrane
was completely inhibited. Therefore, at 4 °C, R8-liposomes appear to enter cells via unique pathway, which is separate and distinct from energy-
dependent vesicular transport. The subsequent nuclear delivery of encapsulated pDNA, when introduced at 4 °C, was less prominent compared
with those introduced at 37 °C. Collectively, these findings demonstrate that a vesicular transport-independent pathway is responsible for the
cellular uptake of liposomes. In addition, the uptake route is closely related to the subsequent nuclear delivery process; the operation of an
endogenous vesicular sorting system is advantageous for the nuclear delivery of pDNA.
© 2006 Elsevier B.V. All rights reserved.Keywords: Intracellular trafficking; PTD; R8; Liposome; Cellular uptake1. Introduction
Improvement in the cellular delivery system for macromole-
cules is an important issue in the area of drug/gene therapy. Recent
studies have revealed that protein transduction domains (PTDs)
are promising devices for improving the delivery of various types
of biologically active molecules [1,2] such as proteins [3–6],
nucleic acids [7–10] and liposomes [11,12]. One of the most
widely studied carrier peptide is derived from human immuno-
deficiency virus-type 1 (TAT) [13,14], which consists of 6 ar-
ginine and 2 lysine residues. Based on the high arginine content
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doi:10.1016/j.bbamem.2006.04.015that consist solely of arginine residue, and characterized their
cellular uptake and intracellular distribution [15–17]. As a result,
it was revealed that an octamer of arginine (R8) showed the most
efficient internalization. In addition, studies in our laboratory
showed that stearylated R8 (STR-R8) was a potent transfection
device, which is capable of efficiently delivering plasmid DNA
(pDNA) into the cell and even into the nucleus [10,18,19].
Moreover, concerning PTD-modified liposomes, Torchilin et al.
compared the cellular uptake of certain types of liposomes, in
which TAT-derived PTD was modified on the liposomes with
various extents of exposure by means of polyethyleneglycol as a
spacer. The findings indicated that liposomes were internalized,
onlywhen TATwas displayed on the surface of the liposome so as
to readily interact with the cell membrane.
Concerning the mechanism for the uptake of PTD ser se or
PTD-modified cargos, initial studies indicated that their uptakewas
not inhibited by incubation at low temperature, a condition inwhich
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result, it was concluded that PTD-modified cargos were taken up
via a vesicular transport-independent pathway (e.g., penetration).
However, a recent report indicated that fixation results in a
significant overestimation of cellular uptake and reorganization
of intracellular distribution [22]. Because of this, mechanism for
the cellular entry has been reexamined using living cells. While
current studies found that this process was energy-dependent,
the mechanism of internalization of PTDs or PTD-cargos at 37 °C
is, however, still controversial, presumably due to differences in
the experimental conditions used. Current candidates for the up-
take pathway include clathrin-mediated endocytosis [10,22–25],
caveolae-mediated endocytosis [26–28] and macropinocytosis
[14,17,29]. We recently demonstrated that physiochemical as-
pects, such as the density of the PTD was a determining factor in
sorting the internalization pathway between clathrin-mediated
endocytosis and macropinocytosis [30]. Furthermore, the exis-
tence of cellular uptake route at low temperature conditions is also
a current topic that needs to be examined. Although some reports
indicated that cellular uptake is diminished by incubation at 4 °C
[10,14,22,28], R8 or heptaarginine modified with a tryptophan
residue in the C-terminus (R7W) were reported to be take up by
cells even at 4 °C [17,31]. Moreover, confocal images indicate
that the intracellular distribution of these peptides were distinct
from that taken up at 37 °C. As a result, the possibility of vesicular
transport-independent internalization in the case of octaarginine
or certain types of PTD peptides cannot be excluded.
The purpose of the present study was to investigate the
mechanism of cellular uptake and the subsequent intracellular
trafficking of R8-modified liposomes introduced at 37 °C and
4 °C in living cells. To accomplish this, we used recently deve-
loped R8-modified liposomes, which are highly associated with
the plasma membrane and are efficiently taken up in an in vitro
cell culture system [33]. To permit R8 to be displayed on the
surface of liposome, it was stearylated, and was then anchored
to lipid vesicles via its stearyl moiety. In addition, a condensed
pDNA was encapsulated into the R8-liposomes so as to
quantitatively evaluate subsequent nuclear delivery by means of
TaqMan PCR, in an attempt to address the relationship between
the intracellular fate and transgene-expression efficiency.
2. Materials and methods
2.1. General
Cholesteryl hemisuccinate (CHEMS), cholesterol (Chol), dioleoyl phos-
phatidyl ethanolamine (DOPE) and Egg yolk phosphatidyl choline (EPC) were
purchased from Avanti Polar lipids (Alabaster, AL, USA). Plasmid DNA en-
coding GFP-luciferase fusion protein (pEGFPluc) was obtained from BD
Bioscience Clontech (Palo Alto, CA USA). Rhodamine-labeled transferrin (Rh-
Tf) and Sulforhodamine B (S-Rho) was purchased from Molecular Probes
(Eugene, OR USA). STR-R8 was synthesized as described previously [18].
2.2. Quantification of cellular uptake of liposomes by flow cytometry
The cellular uptake of R8-liposomes and Rh-Tf was assessed by flow
cytometry. Liposomes composed of EPC, Chol and STR-R8 (7:3:0.5 molar
ratio) were prepared by the hydration method. A lipid film was produced by
evaporation of a chloroform solution of 20 μmol lipids with a rotary evaporatorunder reduced pressure in a round-bottom flask to give a thin film. Hydration
buffer (2 ml), PBS containing 1 mM of S-Rho was then added followed by
vortexing to hydrate the lipid. Size was controlled by extrusion with a Mini-
Extruder (Avanti Polar Lipids), through polycarbonate membrane filters (Nuc-
lepore) with 400, 200 nm pore diameter (11 times each) and 100 nm pore
diameter (21 times). Unencapsulated S-Rh was separated on a Bio-Gel A-1.5 m
column (100–200 mesh) equilibrated with PBS. For the quantification of
cellular uptake, NIH3T3 cells were seeded at a density of 1.0×105 cells per 6-
well plate in growth media. After 24 h, the cells were pre-incubated for 30 min at
37 or 4 °C then incubated with R8 liposomes (0.1 mM) or Tf-TMR (tetramethyl
rhodamine) (2 μM) in serum free medium for 1 h. Cell surface-bound R8-
liposomes were removed as demonstrated previously with minor modifications
[23]. Lundberg et al. showed that TAT-GFP, R8-GFP or K8-GFP protein con-
jugates bound to the cellular surface were nearly completely washed out by a
single wash with PBS supplemented with heparin (5 unit/ml) [23]. However, this
procedure was not sufficient to completely remove surface-bound R8-lipo-
somes, presumably due to strong binding via its high density of R8-moiety (data
not shown). To solve this problem, cells were washed 3 times with ice-cold PBS
supplemented with a higher concentration of heparin (20 units/ml) for 3 times.
Cellular binding of R8-liposomes encapsulating S-Rho was assessed by con-
focal laser scanning microscopy. After the incubation of cells with R8-liposomes
at 37 °C for 1 h, cell-surface binding of R8-liposomes encapsulating S-Rho were
clearly observed without a wash (Fig. 1A). In contrast, after the washing with
PBS supplemented with heparin (20 units/ml), cell-surface binding of R8-lipo-
somes were rarely observed as shown in Fig. 1B. Therefore, this condition is
adequate for removing cell surface-bound R8-liposomes. For the analysis by
flow cytometry, cells were once washed with PBS supplemented with heparin
(20 units/ml), and then trypsinized and collected in an eppendorf tube, and then
washed two additional times by repeating the precipitation of the cells by cen-
trifugation (1500 rpm, 4 °C, 5 min) and resuspension in 1 ml of heparin-PBS.
Finally, cells were suspended in 1 ml of PBS. The cell suspension was then
filtered through a nylon mesh to remove cell aggregates and dust, and cells were
analyzed with a flow cytometer (FACScan, Becton Dickinson).
2.3. Encapsulation of pDNA to the R8-modified liposome
For the quantification of cellular uptake and the nucleus-association of
liposomes, plasmid DNA (pDNA) was encapsulated in R8-liposomes as des-
cribed previously [32]. pDNA (0.1 mg/ml) was then condensed with poly-L-
lysine by mixing equal volumes of these solutions at a charge ratio of 2.4 by
vortexing at room temperature. After the condensation, a lipid film was pro-
duced by evaporation of a chloroform solution with 137.5 nmol of lipid (DOPE/
CHEMS=9:2 (molar ratio)) on the bottom of the glass tube. Then, 0.25 ml of the
complex solution was added, followed by incubation for 10 min to hydrate the
lipids. The final solution of the lipid was 0.55 mM. The hydrated solution was
sonicated in a bath-type sonicator (125W, Branson Ultrasonics, Danbury, CT) to
complete the packaging. Finally, the surface of the liposomes was modified with
R8 by incubation with a STR-R8 (5 mol% lipids) solution for 30 min at room
temperature. Consistent with our previous report, we denote this pDNA-encap-
sulating R8-liposome as an R8-modified multifunctional envelope-type nano
device (R8-MEND) [32].
2.4. Quantification of cellular uptake and nucleus—association of
pDNA-encapsulating liposomes by TaqMan PCR
For the cellular uptake study, 2×105 cells were seeded on a 6-well cell culture
plate for 24 h. The cell culture medium was then replaced with 1 ml of FCS-free
media and the suspension was incubated for 30 min at 37 °C or 4 °C. The R8-
MEND corresponding to 2 μg of pDNA (24 nmol of total lipid) was added,
followed by an additional incubation for 1 h. As a control study, 2 μg of pDNA
condensed with LipofectAMINE PLUS (Invitrogen, Carlsbad, California, USA)
following the manufacturer's protocol was used. Cells were washed 3 times with
PBS supplemented with heparin (20 units/ml) to remove cell surface-bound R8-
MEND. To quantify the nuclear association of pDNA, the nuclear fraction was
further purified. It is likely that cationic R8-MEND after binding on the cell
surface may become redistributed to the outer surface of the nucleus during the
purification procedure. To exclude this possibility, all of the purification
Fig. 1. Heparin-dependent removal of R8-liposomes from cellular surface. R8-liposomes encapsulating S-Rho were incubated for 1 h at 37 °C. Without washing (A),
cellular binding of R8-liposomes was observed (arrowhead). After washing with ice-cold PBS supplemented with heparin (20 U/ml) for 3 times (B), cellular binging of
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which was originally used for removing the cell surface-bound lipoplex. This
reagent is capable of washing out the nuclear surface-bound R8-MEND, and to
also interrupt the redistribution of the cytoplasmic R8-MEND to the nuclear
fraction during the purification of the nuclei. In fact, after the incubation of R8-
MEND and isolation of the nuclei in the presence of CellScrub buffer, the nuclear
distribution was negligible (less than 0.1% of applied R8-MEND). The heparin-
washed cells were suspended in 375 μl of CellScrub Buffer, and 125 μl of cell
lysis solution (2% IGEPAL CA630, 40 mM NaCl, 12 mM MgCl2 and 40 mM
Tris–HCl, pH 7.4) was then added. The suspension was centrifuged at 9200×g
for 2 min at 4 °C, and the supernatant was removed. This procedure was repeated
3 times. The final pellet was used as the nuclear fraction.
DNA was purified from cell lysates or an isolated nucleus by means of a
GenElute Mammalian Genome DNA Miniprep kit (Sigma-Aldrich, St. Louis,
MO), and subjected to TaqMan PCR with ABI PRISM® 7700 Sequence
Detection System (Applied Biosystems) as reported previously [33]. As a ref-
erence, a dilution series of pDNA3.1-GL3 was run along with the samples. The
sequence of the probewas 5′-CCGCTGAATTGGAATCCATCTTGCTC-3′with
FAM as a fluorescent dye on the 5′ end and TAMRA as a fluorescence quencher
dye at the 3′ end. This probe is designed to anneal to the target between the sense
primer (5′-TTGACCGCCTGAAGTCTCTGA-3′) and the antisense primer (5′-
ACACCTGCGTCGAAGATGTTG-3′) in the luciferase pDNA sequence. The
number of β-actin DNA was also determined by the ABI PRISM® 7700 Se-
quence Detection System. PCR was performed according to the manufacturer's
instructions with 0.5 μM each of the respective forward: 5′-TGCGTGACAT
TAAGGAGAAGCTGTG-3′ and reverse: 5′-CAGCGGAACCGCTCATTGC
CAATGG-3′ primers, and QuantiTect SYBR Green PCRMaster Mix (Qiagen,
Hilden, Germany). A linear relationship between the number of cells and the
threshold cycle for theβ-actin gene amplification was confirmed (data not shown).
The amount of nucleus-associated pDNAwas normalized by the number of nuclei
quantified by the copy number of β-actin DNA.
2.5. Imaging of intracellular liposomes by confocal laser scanning
microscopy
1×105 cells were seeded in 2 ml of cell culture medium on a 35 mm/GLASS
BASE DISH (IWAKI, Chiba Japan) for 24 h. Plasma membranes were stained
with PKH67 GREEN FLUORESCENT CELL LINKER (Sigma-Aldrich; St.
Louis, MO USA) following to the protocol with some arrangements. After
washing the cells were with serum-free medium, 100 μl of a PKH67 LINKER
solution (10 μM) was added, and the cells were further incubated for 5 min at
room temperature. The staining reaction was terminated by dilution of medium
with 100 μl of serum-free medium. For the imaging of liposomes introduced at
37 °C and 4 °C, the cells were washed 3 times with 1 ml of PBS adjusted to therespective temperature. After washing, R8-liposomes encapsulating sulforhoda-
mine (S-Rho) were immediately added, followed by incubation for 1 h at 37 °C
and 4 °C, respectively. The cells were then washed with 1 ml of PBS containing
heparin 3 times, and the cell culture medium was exchanged with 1 ml of Krebs-
Henseleit Buffer. Confocal images were captured by a Zeiss Axiovert 2000
inverted fluorescence microscope equipped with a 63× NA 1.4 Planachromat
objective (Carl Zeiss Co. Ltd., Jena, Germany). During the observation of cells,
the temperature of the dish was rigorously controlled by means of a 0 °C∼65 °C
thermo-control system (Carl Zeiss Co. Ltd.).
2.6. Assessment of transfection activity
For the transfection study, 4×104 cells were seeded on a 24-well plate and
allowed to stand for 24 h. Before the transfection, the cell culture medium was
replaced with 250 μl of serum-free medium, and then incubated for 37 °C or
4 °C for 30 min. R8-MEND corresponding to 0.4 μg pDNA was then added,
followed by further incubation for 1 h at 37 °C or 4 °C. After the incubation, the
cells were washed with 500 μl of PBS containing 20 units/ml of heparin sulfate 3
times, and heparin-free PBS 1 time. The cells were incubated with 1 ml of
DMEM containing 10% fetal calf serum and incubated in a CO2 incubator. At
the indicated times, the cells were washed with PBS, and solubilized with re-
porter lysis buffer (Promega, Madison, WI). The luciferase activity was initiated
by the addition of 50 μl of luciferase assay reagent (Promega) into 20 μl of the cell
lysate, and measured by means of a luminometer (Luminescencer-PSN, ATTO,
Japan). The amount of protein in the cell lysate was determined using a BCA
protein assay kit (PIERCE, Rockford, IL).
3. Results
3.1. Evaluation of the effect of temperature on the cellular
uptake of R8-liposomes
The cellular uptake of R8-liposomes encapsulating S-Rho
was investigated by flow cytometry at 37 °C and 4 °C. The size
and ζ-potential of the prepared liposome are summarized in
Table 1. Transferrin (Tf), a common marker of clathrin-depen-
dent endocytosis, was used as a control to evaluate the inhibition
of energy-dependent vesicular transport at 4 °C. Without wa-
shing the surface-bound liposomes, a comparable or higher
degree of cellular association was observed after the incubation
at 4 °C compared with that after the incubation at 37 °C (data not
Table 1
The size and ζ potential of prepared liposome
Size (nm) ζ potential (mV)
R8-liposome 103.3 ± 11.8 37.2 ± 6.8
R8-MEND 297.9 ± 41.3 39.5 ± 12.4
The hydrodynamic diameter was measured by quasi-elastic light scattering by
means of an electrophoresis light scattering spectrophotometer.
Fig. 3. Quantitative comparison of the uptake of R8-MEND introduced at 37 °C
and 4 °C. NIH3T3 cells were incubated with the R8-MEND at 37 °C and 4 °C
for 1 h to evaluate cellular uptake. Uptake was quantified in terms of the number
of copies of luciferase genes by TaqMan-PCR. Closed and open bar represents
cellular uptake of pDNA quantified by TaqMan PCR after the incubation at
37 °C and 4 °C, respectively. Cellular association was normalized by the number
of cells, which is quantified by the number of copies for genomic β-actin gene.
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moved the cell surface bound of R8-liposomes (see Materials
and methods). Even after the removal of surface bound lipo-
somes, a FACS analysis revealed that the internalization of R8-
liposomes was only slightly inhibited at the low temperature
used (Fig. 2A), while the internalization of Tf was significantly
inhibited (Fig. 2B). The mean fluorescence intensity of 10,000
analyzed cells is shown in Fig. 2C. Approximately 80% of the
cellular uptake of R8-liposomes was retained, even at 4 °C,
while uptake of Tf was drastically decreased to approximately
30%.
To quantify cellular uptake and following nuclear delivery by
TaqMan PCR, plasmid DNA was also encapsulated in the R8-
liposome. Here, we denote this liposome as R8-MEND, consis-
tent with a previous report [32]. Compared with R8-liposomes
encapsulating S-Rho, the size of the R8-MEND was approxi-
mately 3-times larger (Table 1). The cellular uptake of the R8-
MEND at low temperature was also confirmed (Fig. 3). As a
control, pDNA condensed by LipofectAMINE PLUS, a com-
mercially available cationic liposome was used, since it was
previously reported that its internalization was severely inhibited
at low temperature [19]. Consistent with the results obtained
with the R8-liposome, a major portion (N50%) of the cellular
uptake of R8-MEND was retained even by incubation at 4 °C,
where the uptake of lipoplex was diminished to less than 30%.
3.2. Mechanism of uptake of R8-liposomes introduced at 37 °C
and 4 °C
The involvement of vesicular transport in the cellular uptake
of R8-liposomes was investigated by means of dual imaging ofFig. 2. Quantitative comparison of the uptake of R8-liposomes introduced at 37 °C a
with NIH3T3 cells in serum free medium for 1 h. After washing with 20 U/ml of h
collected by centrifugation, and resuspended in 100 μl of PBS. The cells were analyz
and thin lines represent the cellular uptake of R8-liposomes introduced at 37 °C and
open bar represents mean fluorescence of analyzed 10000 cells after the incubationan R8-liposome encapsulating S-Rho and PKH67-labeled plas-
ma membrane. After incubation at 37 °C for 1 h, the major
fraction of the R8-liposomes was co-localized with intracellular
vesicular structures, suggesting that R8-liposomes are mainly
taken up to the cells by vesicular transport (Fig. 4A). Some
liposomes were detected as red clusters close to the nucleus,
suggesting that liposomes were partially released from the vesi-
cular compartment. When incubated at 4 °C, the fluorescence
signals of PKH67were dominantly detected on the surface of the
cells, suggesting that the vesicular transport system was severely
interrupted under these conditions (Fig. 4B), whereas a small
number of green clusters were still observed just beneath the
plasma membrane. Even under these conditions, the fluore-
scence signal of S-Rho was detected in the intracellular region.
Magnified images further reveled that intracellular signals cor-
responding to S-Rho (indicated as red arrowheads in Fig. 4B;
inset 1) were detected close to the green signals derived from
the PKH67 signal (indicated as green arrowheads in Fig. 4B;
inset 1), but were not colocalized with each other. In this case,nd 4 °C. R8-liposomes encapsulating S-Rho (A) and Rho-Tf (B) were incubated
eparin, the cells were detached by treatment with a trypsin solution. Cells were
ed with a flow cytometer, and the mean fluorescence was then plotted (C). Thick
4 °C (A and B). Hatched lines represent the non-treated control. (C) Closed and
at 37 °C and 4 °C, respectively.
Fig. 4. Dual imaging of the R8-liposome encapsulating S-Rho and plasma membrane labeled with PKH67. After staining the plasma membrane with PKH67, R8-
liposomes encapsulating S-Rho were immediately added, followed by incubation for 1 h at 37 °C (A) and 4 °C (B), respectively. Fluorescence images were captured by
means of confocal laser scanning microscopy. During the observation of images, the temperature of the dish was rigorously controlled by 37 °C or 4 °C by a thermo-
control system. The white and red arrowhead in (B; inset 1 and 2, respectively) indicates intracellular R8-liposomes taken up at 4 °C. Green arrowhead in inset 2
represented intracellular PKH67 signals.
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invagination, followed by their rapid escape to the cytosol.
Moreover, some red signals were far away from the green
signals (Fig. 4B; inset 2). This indicates that the R8-liposomes
were alternatively internalized via vesicular transport-indepen-
dent pathway. Confocal images also revealed that R8-liposomes
were localized close to the plasma membrane (Fig. 3B:
arrowhead), but were not localized on peri-nuclear region.
3.3. Nuclear association and trans-gene expression of
R8-MEND introduced at 37 °C and 4 °C
The nuclear association of R8-MEND after the internalization
at 37 °C and 4 °C (denoted as R8-MEND37 and R8-MEND4) was
quantified by means of TaqMan PCR (Fig. 5A). After the incu-
bation of R8-MEND for 1 h at 37 °C and 4 °C, the cells wereFig. 5. Time profiles for the nuclear associating pDNA and transfection activity after th
MEND at 37 °C and 4 °C, cells were washed with heparin to remove the memb
fractionation followed by TaqMan PCR. The number of the nucleus-associated pDNA
actin genome. (B) Transfection activity of R8-MEND introduced at 37 °C and 4 °C at
represented as closed and open circle, respectively. The vertical axis represents luciwashed with a heparin solution to remove cell surface-bound R8-
MEND, and further incubated at 37 °C for the indicated times.
The nuclei were fractionated, and nucleus-associated pDNAwas
subsequently quantified by TaqMan PCR. A peak for the nuclear
association of R8-MEND37 appeared within 3 h, while the peak
for R8-MEND4 was observed at 6 h. These data indicate that the
R8-MEND37 reached the nucleus more rapidly than R8-MEND4.
The percent of nucleus-associated pDNA to the totally internal-
ized one (Fnuc) is summarized in Table 2. Comparing the Fnuc at
the time of peaking (at 3 h for the R8-MEND37 versus at 6 h for
the R8-MEND4), the R8-MEND37 showed an approximately 4.6
times higher value than that of R8-MEND4, (24.8% vs. 5.43%).
Collectively, R8-MEND37 was able to gain access to the nucleus
more rapidly andmore efficiently comparedwith theR8-MEND4.
To compare the transgene expression between R8-MEND37
and R8-MEND4, cells were incubated at 37 °C for the indicatede introduction of R8-MEND at 37 °C and 4 °C. (A) After the introduction of R8-
rane-bound R8-MEND. Nucleus-associated pDNA was quantified by nuclear
was normalized by the number of nucleus quantified by the copy number of β-
the indicated times. The results obtained for the incubation at 37 °C and 4 °C are
ferase activity expressed as relative light units (RLU)/mg protein.
Table 3
Comparison of the transfection efficiency normalized by nuclear pDNA
transfected by R8-MEND37 and R8-MEND4
Time post-injection (h)
6 h 24 h
37 °C 1.18 × 103 1.45 × 104
4 °C 23.1 58.5
Transfection activity and nuclear pDNA at 6 h and 24 h was based on Fig. 5A
and B, respectively. Values are expressed as RLU/mg protein/copy.
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indicated times, the transgene-expression of the R8-MEND37
was 2- or 3- orders of magnitude higher than that for the R8-
MEND4. It should be noted that the transfection activity of the
R8-MEND incubated at 37 °C and 4 °C was comparable, when
the cell surface-bound R8-MEND was not removed by heparin
sulfate treatment (data not shown). This strongly suggests that
the intracellular trafficking of R8-MEND introduced in the cells
at 4 °C was distinct from that of the plasma membrane-bound
R8-MEND after cell culture medium was warmed from 4 °C to
37 °C. The amount of protein in the wells showed quite com-
parable values between R8-MEND37 and R8-MEND4 (data not
shown). Therefore, the prominent difference in transgene ex-
pression cannot be accounted for by cytotoxic effects during the
incubation at 4 °C. Finally, “transgene expression normalized
by nuclear pDNA” was compared at two time points (Table 3)
[34]. At 6 h, R8-MEND37 exhibited dramatically higher values
(51-fold) compared with that of R8-MEND4. Moreover, at 24 h,
the difference was greater (247-fold). These data suggest that
the intrinsic activity of pDNA to produce a gene product was
significantly impaired, when introduced by R8-MEND4 com-
pared with that introduced by R8-MEND37.
4. Discussion
Recent studies have indicated that vesicular transport plays
an important role in the cellular uptake of PTD-modified cargos
[10,14,17,22–29]. Inhibitors and/or biomarkers for various ve-
sicular transport systems were used in attempt to identify the
pathway responsible for cellular uptake. These studies revealed
that clathrin-mediated endocytosis [22,23,30], macropinocyto-
sis [14,17,29,30] and caveolae-mediated endocytosis [26] are
all involved in the uptake of PTD peptides ser se, or PTD-
modified proteins, while major determining factor in sorting the
internalization pathway remains obscure. Vesicular transports
are driven by coupling with ATP hydrolysis. Therefore, these
pathways should be inhibited at low temperatures. In fact, the
cellular uptake of transferrin was drastically inhibited to ap-
proximately 30%. In the present study, the majority of R8-lipo-
someswere taken up by cells, even at 4 °C. Initial studies indicated
that PTD is able to penetrate the cells via endocytosis-indepen-
dent pathways since cellular uptake was unaffected by low-
temperature incubation and with endocytosis inhibitors [13].
Whereas these results were artifacts resulting from cell fixation
[22], recent studies using living cells still support the inter-
nalization of a certain kind of PTD even at the low temperatureTable 2
Efficiency of nuclear association of R8-MEND37 and R8-MEND to the totally
internalized MENDS
Uptake
(copies/cell)
Percent of nuclear association of pDNA to
the total cellular uptake
3 h 6 h 10 h 24 h
37 °C 5.05×104 24.8 14.3 11.1 2.40
4 °C 2.96×104 3.53 5.43 4.82 1.91
The efficiency of nuclear association was represented as a percent of nuclear
association of pDNA to the total cellular uptake.[17,31]. Nakase et al., quantitatively compared the cellular up-
take of R8 by the incubation at 37 °C and 4 °C, and found that
approximately 60–70% of the cellular uptake of R8 was re-
tained on incubation at 4 °C [17]. This is consistent with our
findings showing that approximately 80% and 50% of the cel-
lular uptake of R8-liposomes and R8-MEND was retained, on
incubation at 4 °C (Figs. 2 and 3).
In contrast to the mechanism for cellular uptake at 37 °C, very
little information is available concerning the uptake at 4 °C. The
involvement of non-vesicular transport in the uptake of R8-lipo-
somes was further investigated by the dual labeling of plasma
membranes with PKH67 and S-Rho encapsulated in the liposomes
(Fig. 3). Since PKH67 stably incorporates a fluorescent dye into
the lipid regions of cell membraneswith its long aliphatic tail, all of
the internalized vehicles after the membrane staining should be
labeled irrespective of the internalization pathway. In this ob-
servation, the temperature of the dishwas carefully kept bymeans
of a thermo-control system, and cell surface-bound R8-lipo-
somes were removed by treatment with a heparin sulfate sol-
ution in order to exclude the possibility that cell-surface bound
R8-liposomes during the incubation at 4 °C were internalized
via an energy-dependent vesicular transport system by tem-
poral and local warming caused by laser irradiation. As a result,
internalization of plasma membranes labeled with PKH67 was
rarely observed at 4 °C (Fig. 4B). Even in this condition, the
internalization of R8-liposome was observed in the cytoplasm,
suggesting that the R8-liposome probably penetrated into the
cells even at 4 °C. Furthermore, the localization of R8-lipo-
somes were restricted to a specific areas in close proximity to
plasma membrane (Fig. 4B: insets 1 and 2), as was also ob-
served for the R8 peptide [17]. This suggested that migration of
R8-liposomes taken up at low temperature was severely restricted.
It has been proposed that guanidinium-rich peptides interact
with negatively charged, bidentate hydrogen bond acceptor
groups of endogenous membrane constituents, forming a mem-
brane-soluble ion pair complex, which then migrates into the
lipid bilayer [35]. However, this hypothesis was only applied to
small molecules (MW ca. b 3000). An alternative pathway such
as temperature-insensitive potocytosis [36] may be responsible
for the translocation of R8-liposomes after the formation of ion
pairs. The temperature-insensitive invagination is supported by
the fact that some PKH-67 signals were observed in the intra-
cellular region, but were restricted to directly beneath the
plasma membrane (indicated as green arrowheads in Fig. 4B;
inset 1). Furthermore, a part of intracellular R8-liposomes were
detected close to the PKH-67 signal (indicated as red arrowhead
in Fig. 4B; inset 1). These findings suggest that R8-liposomes
719A. Iwasa et al. / Biochimica et Biophysica Acta 1758 (2006) 713–720were partially taken up by temperature-insensitive potocytosis,
followed by rapid release to the cytosol. In addition, some R8
liposomes were detected in the intracellular region away from
the PKH67 signal (indicated as white arrowhead in Fig. 4B;
inset 2), suggesting that alternative mechanism such as pene-
tration may also play a role. The cellular uptake of R8-MEND
was more temperature-sensitive compared to the R8-liposome
(50% vs. 20% inhibition) as shown in Figs. 2C and 3. Since the
mean diameter of the R8-MEND was significantly larger than
that of R8-liposomes (Table 1), smaller sized of macromole-
cules may be more acceptable to these temperature-independent
cellular uptake mechanisms. An investigation of molecular me-
chanism for the cellular uptake is ongoing in our laboratory.
In the 37 °C incubation, R8-liposomes, free from the co-local-
ization with plasma membranes, were observed at the perinuclear
region, which is distinct from the localization of R8-liposomes
incubated at 4 °C. These liposomes could thenbe transported to the
perinuclear region by intracellular sorting by vesicular trafficking,
and then released to the cytosol. Some recent studies indicated that
the endosomal escape of PTD is inhibited by ammonium chloride
[25] or chroloquine [37]. Thus, it is possible that the endosomal
escape of R8-liposomes is coupled with acidification in the vesic-
ular compartment. In this sense, clathrin-mediated endocytosis
[22] or macropinocytosis [23] is a more plausible uptake pathway
for the R8-liposomes compared with caveolae-mediated endocy-
tosis [26], since the pH in caveolae does not decrease after
invagination. In fact, we have demonstrated that cellular uptake
R8-liposomes used in the present study were inhibited by
amiloride, which is a inhibitor of the macropinocytosis [30].
Considering the relationship between intracellular fate and time
profiles for nuclear association, the findings strongly suggest that
the involvement of vesicular transport to the peri-nuclear region is
advantageous for the rapid and efficient nuclear delivery of R8-
MEND introduced at 37 °C (Fig. 5A and Table 2). As mentioned
above, R8-MEND37 appears to be released from vesicular com-
partments that are close to the nucleus after active vesicular
transport, while R8-MEND4 appears to be directly introduced to
the cytoplasm in close proximity to the plasma membrane. There-
fore, R8-MEND4 needs to travel longer distance in the cytoplasm
to reach the nucleus compared with the R8-MEND37. It has been
reported that the movement of macromolecules in the cytoplasm
is severely restricted [38]. If this is true, then, the speed and
efficiency of R8-liposomes for reaching the nucleus is closely
related to the distance from the cytoplasmic R8-liposome to the
nucleus. In fact, Daum et al., indicated that the trans-gene ex-
pression of pDNA microinjected into the cytoplasm far from the
nucleus was much lower than that injected close to the nucleus.
Finally, time profiles for the transgene expression were eva-
luated. At 37 °C, transgene expression was peaked at 12 h and
then decreased slightly (approximately 30% of the peak luci-
ferase activity) at 24 h, which is inconsistent with the fact that
nuclear pDNA peaked at 3 h and then decreased monotonically.
The synthesis of proteins is a product of the nuclear transcrip-
tion of pDNA and subsequent translation. As a result, time lag
between peak of nuclear pDNA (within 3 h) and luciferase
activity (12 h) may be derived from the time required for the
nuclear transcription and translation. Concerning the elimina-tion process, a decrease in transgene expression from 12 h to
24 h was less prominent than that of nuclear pDNA. Since the
apparent luciferase activity is balanced by synthesis and clear-
ance of gene products, the inefficient clearance of a gene pro-
duct may reflect the moderate luciferase activity, even though
biosynthesis may be reduced in response to the time-dependent
decrease in nuclear pDNA. In this sense, “transgene expression
normalized by nuclear pDNA” calculated as the trans-gene ex-
pression divided by the gene copies in the nucleus (Table 3) is
not necessarily a direct index of intrinsic activity of pDNA for
the biosynthesis. However, if the intrinsic activity of pDNA to
produce the gene product was comparable between R8-MEND37
and R8-MEND4, “transgene expression normalized by nuclear
pDNA” (Table 3) may represent comparable values based on
the hypothesis that the clearance of a gene product should be
comparable regardless of the conditions used for the introduc-
ing the R8-MEND. R8-MEND37 exhibited approximately a
500 times higher trans-gene expression compared with R8-
MEND4 (Fig. 5B). In comparing “transgene expression norma-
lized by nuclear pDNA”, R8-MEND37 shows 2- or 3 orders of
magnitude higher values than those of R8-MEND4 (Table 3).
As mentioned in Materials and methods, the core particle of
pDNA condensed with polycations was coated with a lipid
envelope (DOPE/CHEMS, a pH sensitive fusogenic lipid com-
position [39,40]) to form the MEND structure [32]. It has been
demonstrated that trans-gene expression after the nuclear mic-
roinjection of pDNA is strongly impaired when it is injected in
the form of a lipoplex [41,42]. suggesting that pDNA should be
free from cationic lipid components so as to be efficiently recog-
nized by intra-nuclear transcription factors. When R8-MEND37
escapes from the vesicular compartment, the lipid envelope is
presumably consumed by fusion with the cellular membrane,
forming a hexagonal structure-II structure in response to the low
intra-vesicular pH [43]. As a result, pDNA encapsulated in an R8-
MEND37 may be more prominently subject to the transcription
process compared with that in the R8-MEND4.
Collectively, it was verified that R8-liposomes, when incu-
bated at a temperature of 4 °C, enter cells via a unique pathway
distinct from that introduced at 37 °C, whereas subsequent
nuclear delivery was less efficient compared with that of R8-
liposomes introduced at a temperature of 37 °C. This conclusion
provides encouragement for using a strategy involving the en-
dogenous vesicular sorting system for the nuclear targeting of
macromolecules.
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